more japan sales data, page-2

I didnt quite grasp the enormity of DS' botched Inavir prevention trials until now.

Assuming we would have gotten very quick regulatory approval, Inavir has so far missed out on about 1.6 billion yen in stockpiling orders (based on 50% of Tamiflu's total stockpiling sales of 3.3 billion in 2011).

Thankfully 2011 was a very quiet year for stockpiling orders. Chugai is also forcasting total stockpiling sales in 2012 at an all-time low of 0.3 billion.

Tamiflu's stockpiling over the years in Japan have been:

35 billion (2005)
38 billion (2006)
38.7 billion (2007)
8.4 billion (2008)
76 billion (2009)
18 billion (2010)
3.3 billion (2011)
0.3 billion (2012 forecast)